Clinical Trial Update: Myobloc Atrophy Study [Phase 4]

View source ↗

Summary

Georgetown University reports completion of a Phase 4 study evaluating Myobloc (rimabotulinumtoxinB) for spasticity in patients with spinal cord injury, traumat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Spasticity
• Spinal Cord Injury
• Stroke
• Traumatic Brain Injury

Drugs mentioned

• MYOBLOC (rimabotulinumtoxinB)

Snippet

Sponsor: Georgetown University | Conditions: Spasticity Secondary to Either a Disorder or Trauma, Spinal Cord Injury (SCI) | Phase 4 | Status: COMPLETED